Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 1637-1647, 2008. First published August 7, 2008; 10.1373/clinchem.2008.103457
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2008.103457v1
54/10/1637    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Schaeffeler, E.
Right arrow Articles by Schwab, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaeffeler, E.
Right arrow Articles by Schwab, M.
(Clinical Chemistry. 2008;54:1637-1647.)
© 2008 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

Highly Multiplexed Genotyping of Thiopurine S-Methyltransferase Variants Using MALDI-TOF Mass Spectrometry: Reliable Genotyping in Different Ethnic Groups

Elke Schaeffeler1, Ulrich M. Zanger1, Michel Eichelbaum1, Steven Asante-Poku2, Jae-Gook Shin3 and Matthias Schwab1,4,a

1 Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany, and University of Tuebingen, Tuebingen, Germany; 2 University of Ghana Medical School, Accra, Ghana; 3 Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea; 4 Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany.

aAddress correspondence to this author at: Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, D-70376 Stuttgart, Germany. Fax +49 711 85 92 95; e-mail matthias.schwab{at}ikp-stuttgart.de.

Background: To avoid severe hematotoxicity in patients, determination of the TPMT (thiopurine S-methyltransferase) genotype before commencing thiopurine therapy has become accepted.

Methods: We used MALDI-TOF mass spectrometry (MS) based on Sequenom iPLEX® technology to develop novel multiplex assays for comprehensive testing of TPMT. Two assays, a 15-plex and a 7-plex assay, consisting of multiplex PCR, shrimp alkaline phosphatase treatment, primer extension, and MALDI-TOF MS analysis, allow detection of all currently known functionally relevant 24 TPMT alleles (TPMT*2 to *18, *20 to *23). Previously identified variant DNA samples and newly constructed synthetic templates were used as quality controls.

Results: Assay evaluation performed on a panel of 586 genomic DNA samples previously genotyped by other methods (denaturing HPLC, sequencing) resulted in 100% agreement. Analyses of the distribution of TPMT alleles in 116 samples from a Ghanaian population revealed a TPMT*8 allele frequency of 3.4%. In a Korean population of 118 unrelated individuals, we found a TPMT*6 allele frequency of 1.3%.

Conclusions: The newly developed multiplex MALDI-TOF MS assay allows efficient genotyping for all currently known functional TPMT variants. To achieve the most accurate prediction of TPMT phenotype, molecular diagnosis of TPMT should include all these variants.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
N. B. Y. Tsui
Multiple Thiopurine S-Methyltransferase Variation Detection: A Step toward Personalized Medicine
Clin. Chem., October 1, 2008; 54(10): 1598 - 1599.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.